science42 %Skin cancer: personalized RNA vaccine cuts recurrence risk by 42%

Skin cancer: personalized RNA vaccine cuts recurrence risk by 42%

A large-scale clinical trial confirms the effectiveness of a custom RNA vaccine against melanoma.

Published 28m1 sourceImportant

Lire en français

≈ 10sSpeed

Click the link to read an article on the topic:

Futura Sciences

Explore this topic

#cancer #mélanome #vaccin #ARN messager #essai clinique #récidive #médecine personnalisée

What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.

Follow topic →

Auto-synthesis from 1 media source · identified on November 15, 2026

← Back to home

Discover

Read more

All science →